Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Somatization disorders of affective and neurotic registers during the COVID-19 pandemic (analysis of clinical cases)

Full Text:


The COVID-19 coronavirus pandemic has added additional difficulties to the differential diagnostic evaluation of the status of patients with disorders of affective and neurotic registers. In such conditions, the works describing and analyzing specific clinical cases are of considerable interest. The paper describes three clinical cases of somatization mental disorders manifesting themselves during the COVID-19 pandemic, with an account of their history, somatic and mental status, psychopathological classification of the condition, and a rationale for the therapy regimen. Itching, dysuria, and hyperventilation without a somatic basis come to the fore in the clinical picture. These somatic symptoms developing in the pattern of mental disorders of the affective and neurotic registers substantially make the diagnosis, specialized care provision, and medical routing of patients difficult. An integrated psychosomatic approach to clinically evaluating psychopathological disorders that are partially realized in dermatological, urological, and pulmonological spheres, contributes to their adequate diagnosis and effective therapy.

About the Author

I. Yu. Dorozhenok
I.M. Sechenov First Moscow Medical University (Sechenov University), Ministry of Health of Russia; Mental Health Research Center
Russian Federation

Igor Yuryevich Dorozhenok

8, Trubetskaya St., Build. 2, Moscow 119991,

34, Kashirskoe Shosse, Moscow 115522


1. Shevlin M, Nolan E, Owczarek M, et al. COVID-19-related anxiety predicts somatic symptoms in the UK population. Br J Health Psychol. 2020 Nov;25(4):875-82. doi: 10.1111/bjhp.12430. Epub 2020 May 27.

2. Askin O, Altunkalem RN, Altinisik DD, et al. Cutaneous manifestations in hospitalized patients diagnosed as COVID-19. Dermatol Ther. 2020 Jun 24:e13896. doi: 10.1111/dth.13896. Epub ahead of print.

3. Mumm JN, Osterman A, Ruzicka M, et al. Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARSCoV-2 Cause Viral Cystitis? Eur Urol. 2020 Oct;78(4):624-8. doi: 10.1016/j.eururo.2020.05.013. Epub 2020 May 19.

4. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213. doi: 10.1111/jdv.16387

5. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30.

6. Ozaras R, Berk A, Ucar DH, et al. Covid-19 and exacerbation of psoriasis. Dermatol Ther. 2020 Jul;33(4):e13632. doi: 10.1111/dth.13632. Epub 2020 Jun 2.

7. Chew NWS, Lee GKH, Tan BYQ, et al. A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak. Brain Behav Immun. 2020 Aug;88:559-65. doi: 10.1016/j.bbi.2020.04.049. Epub 2020 Apr 21.

8. Lai J, Ma S, Wang Y, et al. Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA Netw Open. 2020 Mar 2;3(3):e203976. doi: 10.1001/jamanetworkopen.2020.3976

9. Еzdin S, Bayrak Еzdin S. Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: The importance of gender. Int J Soc Psychiatry. 2020 Aug;66(5):504-11. doi: 10.1177/0020764020927051. Epub 2020 May 8.

10. Zou X, Chen K, Zou J, et al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020 Apr;14(2):185-92. doi: 10.1007/s11684-020-0754-0. Epub 2020 Mar 12.

11. Reyes R, Bono G, Finucane T. «Urinary Tract Infection» in the Era of COVID-19. J Am Geriatr Soc. 2020 Jun 17;10.1111/jgs.16685. doi: 10.1111/jgs.16685. Online ahead of print.

12. Mazza MG, De Lorenzo R, Conte C, et al; COVID-19 BioB Outpatient Clinic Study group; Benedetti F. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020 Oct;89:594-600. doi: 10.1016/j.bbi.2020.07.037. Epub 2020 Jul 30.

13. Lenze EJ, Mattar C, Zorumski CF, et al. Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients with Symptomatic COVID-19: A Randomized Clinical Trial. JAMA. 2020 Nov 12. doi: 10.1001/jama.2020.22760. Epub ahead of print.

14. Colizzi M, Bortoletto R, Silvestri M, et al. Medically unexplained symptoms in the times of COVID-19 pandemic: A case-report. Brain Behav Immun Health. 2020 May;5:100073. doi: 10.1016/j.bbih.2020.100073. Epub 2020 Apr 19.

15. Shangguan F, Quan X, Qian W, et al. Prevalence and correlates of somatization in anxious individuals in a Chinese online crisis intervention during COVID-19 epidemic. J Affect Disord. 2020 Dec 1;277:436-42. doi: 10.1016/j.jad.2020.08.035. Epub 2020 Aug 23.

16. Javelot H, Weiner L. Panic and pandemic: Review of the literature on the links between panic disorder and the SARS-CoV-2 epidemic. Encephale. 2020 Jun;46(3S):93-8. doi: 10.1016/j.encep.2020.05.010. Epub 2020 May 21.

For citation:

Dorozhenok I.Yu. Somatization disorders of affective and neurotic registers during the COVID-19 pandemic (analysis of clinical cases). Neurology, Neuropsychiatry, Psychosomatics. 2020;12(6):137-143. (In Russ.)

Views: 294

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)